SCHEMBL3600883

SCHEMBL3600883

CC(C)(C)N(C(=O)O)[C@](C)(Cc1ccccc1)C(O)CN

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.40
CYP1A2 P05177 1/20 0.40
RECQL P46063 1/20 0.40
TRPA1 O75762 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
HIF1A Q16665 1/20 0.39
MAPK1 P28482 1/20 0.39
SLC6A2 P23975 2/20 0.39
TAAR1 Q96RJ0 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
RIPK1 Q13546 2/20 0.36
SLC6A4 P31645 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2024172 1.00 CYP3A4 (0.40) CYP3A4CYP1A2RECQLTRPA1SMN1; SMN2
SCHEMBL2212129 0.76 CYP3A4 (0.43) CYP3A4CYP1A2RECQLSMN1; SMN2HIF1A
SCHEMBL12417601 0.73 TRPA1 (0.59) CYP3A4CYP1A2RECQLTRPA1SMN1; SMN2
SCHEMBL19384865 0.72 TRPA1 (0.42) CYP3A4TRPA1SMN1; SMN2HIF1ASLC6A2
SCHEMBL2349672 0.71 MEN1 (0.43) CYP3A4CYP1A2RECQLSMN1; SMN2HIF1A
SCHEMBL3595900 0.71 MEN1 (0.43) CYP3A4CYP1A2RECQLTRPA1SMN1; SMN2
SCHEMBL2023058 0.71 MEN1 (0.43) CYP3A4CYP1A2RECQLTRPA1SMN1; SMN2
SCHEMBL3594929 0.71 CYP3A4 (0.48) CYP3A4CYP1A2RECQLTRPA1SMN1; SMN2
SCHEMBL4743524 0.71 CYP3A4 (0.48) CYP3A4CYP1A2RECQLTRPA1SMN1; SMN2
SCHEMBL2026162 0.70 MEN1 (0.45) CYP3A4CYP1A2RECQLSMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7847100-B2 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease Merck, Sharp & Dohme, Inc. (US) 2010-12-07 US disclosed
US-20070244119-A1 1,3,5-Substituted Phenyl Derivative Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease MERCK SHARP & DOHME LLC 2007-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244119-A1 1,3,5-Substituted Phenyl Derivative Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease BACE1, BACE2, PSEN1 CYP3A4 1045/4885CYP1A2 1158/4885RECQL 3009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.